Elisabeth G. Cain, PA-C

Elisabeth Cain practices at Southern Marin Dermatology, Inc. in Sausalito, California.

Elisabeth Cain's NPI, 1750701736, was assigned on April 17, 2014. Elisabeth Cain holds New Hampshire license 1017.

Elisabeth Cain's primary practice is Southern Marin Dermatology, Inc., at 2330 Marinship Way, Sausalito, CA 94965 in Marin County. The practice phone is (415) 887-9758.

Elisabeth Cain's primary practice is Southern Marin Dermatology, Inc. in Sausalito, California. The medical group on file is Southern Marin Dermatology. Dmand AI also links Elisabeth Cain to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Elisabeth Cain practices. Vendor and product names are available with a free account.

Physician assistant is Elisabeth Cain's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Elisabeth Cain is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Dmand AI has Elisabeth Cain's licenses on file in 2 states: New Hampshire and California.

Dmand AI lists acne, acute skin infection, ankle or foot injury, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, head wound and itchy rashes among the conditions Elisabeth Cain treats.

CMS data shows 272 Medicare services from Elisabeth Cain across 6 procedure codes in 2024, for 89 Medicare patients. Medicare paid $13,497 for them. Every service was in an office.

CMS counts 89 Medicare patients who saw Elisabeth Cain in 2024. The largest group is 65 to 74, with 47 patients. 74% of them have high cholesterol, and 52% have high blood pressure. Their average risk score is 0.92, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Elisabeth Cain's median patient age at 56, with 100% women.

In 2024, Elisabeth Cain wrote 132 Medicare Part D claims for 54 patients. 76% of them were for generic drugs. CMS names the drug for 61 of them, across 4 drugs with 11 or more claims each, at $132,192 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Elisabeth Cain for performance year 2024, reported as part of a group. Elisabeth Cain accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 60 general payments to Elisabeth Cain from 14 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $839.